ReNAgade NEWS & PRESS RELEASES

We’re rapidly and relentlessly advancing transformational RNA medicines.

See the headlines our progress has inspired.

February 2024

Evercore ISI 2024 Emerging Biotech Conference Webcast

Thursday, February 29, 2024 at 9:35 a.m. ET

Click here for webcast

Investor Relations Contact:

Emily Brabbit, Argot Partners
(212) 600-1902
renagade@argotpartners.com

Media Relations Contact:

Sarah Sutton, Argot Partners
(212) 600-1902
renagade@argotpartners.com

“RNA without limits”, “Deliver-Code-Edit-Insert” are trademarks of ReNAgade Therapeutics, Inc.